If you have been reading about Cyclic heptapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-19. Where a claim depends on a specific study, the study is described rather than over-claimed.
The lactam ring that closes the peptide backbone improves resistance to exopeptidase attack, but the molecule stays susceptible to hydrolysis and oxidation once dissolved. Degradation accelerates with temperature, extreme pH, and light exposure, and repeated freeze-thaw cycles promote aggregation and material loss. Lyophilized powder held desiccated at or below minus twenty degrees Celsius is the common way to keep reference material. Reconstituted solutions are generally kept cold and used within a short window because their stability is far lower than that of the dry solid.
Handling procedures emphasize minimizing moisture uptake, since the dried solid is hygroscopic and can draw water when warmed to room temperature before a vial is opened. Laboratories record lot number, purity, counter-ion content, and residual solvent data supplied by the producer. Impurity profiles are compared run to run, and any shift in retention time or peak shape prompts re-verification against a reference standard. Certificates of analysis are treated as claims to be checked rather than accepted at face value.
Identity and purity testing for this peptide typically relies on reversed-phase high-performance liquid chromatography with ultraviolet detection, reported as area-percent purity. Mass spectrometry, usually in tandem mode, confirms molecular mass and supports quantification in biological matrices. Sequence confirmation may use peptide mapping after enzymatic digestion, while nuclear magnetic resonance and circular dichroism supply supplementary structural detail. No single technique establishes identity alone, so laboratories compare retention time, mass, and fragment pattern against a verified reference standard.
Clinical development of bremelanotide proceeded through several reformulation attempts. An early intranasal version was discontinued, and a subcutaneous auto-injector formulation later received approval for hypoactive sexual desire disorder in premenopausal women. Approval decisions have varied by country and over time, and the product has not been universally adopted. Blood pressure elevation is a documented effect, which is why some jurisdictions require monitoring after administration. The clinical evidence base continues to evolve as additional studies are published.
Bremelanotide is a cyclic heptapeptide that acts as an agonist at melanocortin receptors. It binds MC1R, MC3R, MC4R, and MC5R, with MC4R activation considered most relevant to sexual desire pathways in the central nervous system. The molecule is a synthetic analog of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and energy regulation. Early research explored its use in tanning before attention shifted toward sexual dysfunction applications. Receptor binding affinity varies across these subtypes.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Lyophilized powder form |
| Solubility class | Freely soluble in water | Also dissolves in polar organic solvents |
| Typical storage temperature | Minus 20 degrees Celsius or lower | Desiccated and protected from light |
| Typical analytical method | Reversed-phase HPLC with UV detection | Purity reported by area normalization |
| Common synonyms | PT-141; bremelanotide | Research code and assigned generic name |
The compound emerged from a research programme examining melanocortin analogues for effects on skin pigmentation. During early human studies, participants reported spontaneous erections as an unexpected side effect, which redirected development toward sexual function rather than tanning. An intranasal formulation was investigated in clinical trials but did not reach market approval. A subcutaneous injectable version later completed the regulatory process, and the nasal route does not appear in approved labelling.
Approved use is narrow and jurisdiction-specific. In the United States, the injectable product is authorised for premenopausal women with acquired, generalised hypoactive sexual desire disorder, a diagnosis that requires documented distress. It is not approved for men, for postmenopausal women, or for use alongside hormonal contraceptives under the approved labelling. Outside regulated markets, the same peptide is frequently sold as a research chemical, where identity, purity, and sterility are not independently verified.
Across literature and commercial listings, the substance appears under several names, including bremelanotide, PT-141, and various brand designations. A CAS registry number provides a unique identifier for the compound, aiding retrieval from chemical databases. Synonym lists may also contain early development codes and descriptive chemical names. When consulting sources, researchers need to confirm that the cited names refer to the same molecular structure to avoid confusion. Naming consistency matters especially when comparing analytical data across publications.
PT-141 is a synthetic cyclic heptapeptide whose development code is bremelanotide. It belongs to the class of melanocortin receptor agonists and acts by mimicking endogenous peptide hormones. The compound originated from research on melanotan II, where investigators exploring derivatives found distinct pharmacological features. Unlike the parent compound, PT-141 showed effects on pathways related to sexual desire and function in early studies, prompting its development as a separate candidate. Its molecular design aimed to separate receptor activity from pigmentary effects.
Clinical programmes in this area have relied mainly on randomised, double-blind, placebo-controlled designs in premenopausal women. Primary endpoints usually combine a validated questionnaire covering desire domains with counts of satisfying sexual events and a separate measure of distress. Reported outcomes show statistically significant but modest average improvement over placebo, with wide individual variation. Adverse events such as nausea, flushing, and headache occur frequently and can limit tolerability. Whether short-term trial gains translate into lasting change for most users is an open question.
Evidence outside the studied population is sparse. Trials have concentrated on premenopausal women with a defined diagnosis, and data for postmenopausal women, men, and people taking interacting medications remain limited. Non-prescription use of the peptide for comparable goals is widespread but is not supported by published controlled data. Observed changes in blood pressure have drawn attention to cardiovascular monitoring during use. The literature generally frames the compound as a targeted receptor agonist rather than a general libido enhancer, and basic questions about mechanism and long-term safety are unresolved.
Reported pharmacodynamic effects include transient rises in blood pressure and heart rate, flushing, nausea and headache, appearing soon after dosing and resolving within hours. These responses were dose-related in early studies and shaped the label's cardiovascular cautions and blood pressure monitoring advice. Gastrointestinal upset is the most frequent reason cited for discontinuation in trials. Whether the vascular signal attenuates with repeated use is not settled. Central effects on desire are described as emerging over weeks rather than immediately, which points to a cumulative rather than acute process.
The compound binds several melanocortin receptor subtypes rather than a single target, with the strongest functional activity reported at MC4R and measurable activity at MC1R, MC3R and MC5R. MC4R populations are dense in hypothalamic nuclei that integrate energy balance, autonomic tone and reproductive behaviour, which is the anatomical basis for the proposed pro-desire effect. Because binding is not subtype-selective, pigmentary and vascular effects accompany central activity. Improving subtype selectivity is an active area of analogue design. Direct causal mapping from receptor occupancy to reported desire change in humans is not fully established.
=== Boston === New England or Boston brown bread is a type of dark, slightly sweet multigrain steamed bread, usually sweetened with molasses. It is popular in New England and traditionally served with baked beans and hot dogs. Boston brown bread's colour comes from a mixture of flours, usually a mix of cornmeal, rye, whole wheat, or graham flour, and from the addition of sweeteners like molasses and maple syrup. Raisins are sometimes added. The batter is poured into a can and steamed in a kettle.
This tunnel contains a set of tight binding pockets such that each side chain of the substrate peptide (P6 to P1') is bound in a complementary site (S6 to S1'). In particular, peptide side chain P6-Glu contacts a network of three hydrogen bonds; P5-Asn points into the solvent, making no specific interactions (hence the absence of substrate consensus at this position); P4-Leu is buried in a hydrophobic pocket; P3-Tyr is held in a hydrophobic pocket with a short hydrogen bond at the end; P2-Phe is also surrounded by hydrophobes including the face of the triad histidine; P1-Gln forms four hydrogen bonds; and P1'-Ser is only partly enclosed in a shallow hydrophobic groove.
Stalin's Gulag was, in many ways, less a concentration camp than a forced labor camp and less a prison system than a system of slavery. The image of the slave appears often in Gulag memoir literature. As Varlam Shalamov wrote: "Hungry and exhausted, we leaned into a horse collar, raising blood blisters on our chests and pulling a stone-filled cart up the slanted mine floor. The collar was the same device used long ago by the ancient Egyptians." Thoughtful and rigorous historical comparisons of Soviet forced labor and other forms of slave labor would be worthy of scholarly attention, in my view. For as in the case of global slavery, the Gulag found legitimacy in an elaborate narrative of difference that involved the presumption of dangerousness and guilt. This ideology of difference and the violence of human exploitation have left lasting legacies in contemporary Russia.
In May 2021, Mesa Grill in Caesars Palace was converted to an Italian restaurant called Amalfi by Bobby Flay. He also updated the menu and changed the name of his Las Vegas Bobby's Burger Palace to Bobby's Burgers. He now has four locations of Bobby's Burgers in Caesars Palace Las Vegas, Paris Hotel Las Vegas, Harrah's Las Vegas, and Yankee Stadium in New York City. As of September 2019, Flay has an estimated net worth of $30 million.
63Ni, with a half-life of 100.1 years, is useful in krytron devices as a beta particle (high-speed electron) emitter to make ionization by the keep-alive electrode more reliable. It is being investigated as a power source for betavoltaic batteries. Around 27% of all nickel production is used for engineering, 10% for building and construction, 14% for tubular products, 20% for metal goods, 14% for transport, 11% for electronic goods, and 5% for other uses. In 2025, QuesTek Innovations and Stoke Space developed a nickel-based superalloy for additive manufacturing and extreme high-pressure, high-temperature oxygen environments. Its characteristics allow the material to be used for fully reusable spacecraft launch systems, it can withstand the full-flow staged combustion rocket engine Zenith. Raney nickel is widely used for hydrogenation of unsaturated oils to make margarine, and substandard margarine and leftover oil may contain nickel as a contaminant. Forte et al. found that type 2 diabetic patients have 0.89 ng/mL of Ni in the blood relative to 0.77 ng/mL in control subjects. Nickel titanium is an alloy of roughly equal atomic percentages of its constituent metals which exhibits two closely related and unique properties: the shape memory effect and superelasticity.
Sources: en.wikipedia.org
The research results (see table) indicate that about 1 in 5 people have a slow transit (type 1 and 2 stools), while 1 in 12 has an accelerated transit (type 5 and 6 stools). Moreover, the nature of the stool is affected by age, sex, body mass index, whether or not they had cholecystectomy and possible psychosomatic components (somatisation); there were no effects from factors such as smoking, alcohol, the level of education, a history of appendectomy or familiarity with gastrointestinal diseases, civil state, or the use of oral contraceptives.
Homozygous Hb Lepore is similar to beta-thalassemia major; however, the clinical course is variable. Patients with this condition typically present with severe anemia during the first two years of life. The heterozygote form is mildly anemic (Hb 11–13 g/dl) but presents with a significant hypochromia (deficiency of hemoglobin in the red blood cells) and microcytosis.
Gary James Player (born 1 November 1935) is a South African retired professional golfer who is widely considered to be one of the greatest golfers of all time. Player won over 160 professional tournaments across six continents, including nine major championships. Following victories at the 1959 Open Championship, 1961 Masters Tournament and 1962 PGA Championship, Player won the 1965 U.S. Open to become the first non-American to win the career grand slam. He was the third golfer to win the modern career grand slam, and only three more players have achieved the feat since. Player was inducted into the World Golf Hall of Fame in 1974. Nicknamed "the Black Knight", "Mr Fitness", and "the International Ambassador of Golf", Player has been prolific as a golf course architect with more than 400 design projects throughout the world. He has also authored or co-written 36 books on golf instruction, design, philosophy, motivation and fitness. In 2021, Player was awarded the Presidential Medal of Freedom by United States president Donald Trump.
== External links == Cobalt-60, Centers for Disease Control and Prevention. NLM Hazardous Substances Databank – Cobalt, Radioactive Beta decay of Cobalt-60, HyperPhysics, Georgia State University. Dr. Henry Kelly (March 6, 2002). "Cobalt-60 as a Dirty Bomb". Federation of American Scientists. Archived from the original on April 5, 2002. Retrieved November 26, 2005.
Sources: en.wikipedia.org
Peña and Javier Milei met on 9 December 2023 and agreed to "deepen" Mercosur. Peña stated that he had placed himself "at Milei's disposal" and attended his presidential inauguration in December 2023. Paraguay's vice minister of commerce, Óscar Stark, stated on 13 December 2023 that the economic policy of the new Argentine government, which aspires to eliminate multiple exchange rates and move toward exchange-rate unification in the short term, works against the smuggler's business and is therefore favorable for Paraguay, and that "it is going to be much easier to talk than with the previous government".
Cellulite ( ) or gynoid lipodystrophy (GLD) is the herniation of subcutaneous fat within fibrous connective tissue that manifests as skin dimpling and nodularity, often on the pelvic region (specifically the buttocks), lower limbs, and abdomen. Cellulite occurs in most postpubescent females. A review gives a prevalence of 85–98% of women of European descent, but it is considerably less common in women of East Asian descent. It is believed to be physiological rather than pathological. It can result from a complex combination of factors, including diet, sedentary lifestyle, hormonal balance, or heredity, among others. It is not specific to females, but it is more common in females than in males.
== See also == Bioenergetic systems Exercise intolerance § low ATP reservoir Exercise intensity § fuel used Purine nucleotide cycle § pathology (low ATP reservoir, ADP>ATP, ↑AMP) Tachycardia § sinus (inappropriate rapid heart rate response to exercise) IST § differential diagnoses (inappropriate sinus tachycardia) Second wind (exercise phenomenon) Inborn errors of carbohydrate metabolism Fatty acid metabolism disorder (fatty acid oxidation disorder, FAOD) Mitochondrial myopathies AMP deaminase deficiency (myoadenylate deaminase deficiency, MADD)
In Canada, cream soda is mostly pink with a taste reminiscent of grenadine, although clear versions can be found in Quebec and Atlantic Canada. Some brands, such as Fanta, market clear cream soda nationwide. Many brands have a long-lasting, foamy head. Brands include:
Some archaeons such as Methanocaldococcus jannaschii do not have a cysteine—tRNA ligase. Instead they probably make cystyl-rRNA in through seryl-tRNA and phosphoseryl-tRNA, analogous to the Sec-tRNA production route in eukarya and archaea. Some bacteria with the Sec machinery also have a noncanonical tRNACysGCA or tRNACysUCA. They are recognized by the usual Cysteine—tRNA ligase, but needs the help of SelB to work. The tRNACysUCA type, also called tRNAReC, can cause Cys to be inserted instead of Sec at UGA. This might help the bacterium cope with a lack of selenium. Some versions of tRNAReC have further mutated to be recognized by the seryl-tRNA synthase and SelA, making them a second kind of tRNASec. This is proposed to be called tRNAReU. ReU is not as efficient as the standard tRNASec. Some bacteria also have so-caleed allo-tRNAs, which have an acceptor domain similar to tRNASec. They appear to cause some other amino acid to be replaced by serine. There are also lab-modified versions of the tRNA-SelAB system.
Sources: en.wikipedia.org
Chemical degradation such as hydrolysis and oxidation proceeds more slowly as temperature falls. Cold storage also limits microbial growth in reconstituted material. Repeated warming should be avoided because thermal cycling stresses the peptide.
Retention time supports consistency but does not establish structure by itself. A different compound can elute at a similar time under one set of conditions. Mass spectrometry or comparison with a verified standard is normally required alongside the chromatographic result.
The lactam bridge constrains the peptide backbone and limits attack by some exopeptidases. It does not protect against hydrolysis of amide bonds inside the ring or against oxidative modification of susceptible residues. Stability therefore still depends heavily on storage conditions.
PT-141 is the research code for bremelanotide, a cyclic peptide developed as a melanocortin receptor agonist. The code has appeared in literature and catalog listings since early development. Bremelanotide is the international nonproprietary name.